Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Hajer Jarraya"'
Autor:
Laurent Basson, Hajer Jarraya, Alexandre Escande, Abel Cordoba, Rayyan Daghistani, David Pasquier, Thomas Lacornerie, Eric Lartigau, Xavier Mirabel
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Purpose: PET/CT is a standard medical imaging used in the delineation of gross tumor volume (GTV) in case of radiation therapy for lung tumors. However, PET/CT could present some limitations such as resolution and standardized uptake value threshold.
Externí odkaz:
https://doaj.org/article/562ee9b22d614f1eb3a457802322eff9
Autor:
Jean-Emmanuel Bibault, Sylvain Dewas, Claire Vautravers-Dewas, Antoine Hollebecque, Hajer Jarraya, Thomas Lacornerie, Eric Lartigau, Xavier Mirabel
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e77472 (2013)
PURPOSE:Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) has been evaluated in several recent studies. The CyberKnife(®) is an SBRT system that allows for real-time tracking of the tumor. The purpose of this study was to
Externí odkaz:
https://doaj.org/article/b98d4653f0d0452f9d1e35462524bf0d
Autor:
Olivier Ernst, Sophie Taïeb, Paul Borde, Andrew Kramar, Xavier Mirabel, Eric Lartigau, Luc Ceugnart, Hajer Jarraya, Thomas Boulanger
Publikováno v:
International Journal of Radiation Oncology-Biology-Physics
International Journal of Radiation Oncology-Biology-Physics, Elsevier, 2015, 92 (2), pp.292-298. ⟨10.1016/j.ijrobp.2015.01.028⟩
International Journal of Radiation Oncology, Biology, Physics
International Journal of Radiation Oncology, Biology, Physics, 2015, 92 (2), pp.292-298. ⟨10.1016/j.ijrobp.2015.01.028⟩
International Journal of Radiation Oncology-Biology-Physics, Elsevier, 2015, 92 (2), pp.292-298. ⟨10.1016/j.ijrobp.2015.01.028⟩
International Journal of Radiation Oncology, Biology, Physics
International Journal of Radiation Oncology, Biology, Physics, 2015, 92 (2), pp.292-298. ⟨10.1016/j.ijrobp.2015.01.028⟩
International audience; OBJECTIVE: The Response Evaluation Criteria in Solid Tumors (RECIST) can have limitations when used to evaluate local treatments for cancer, especially for liver malignancies treated by stereotactic body radiation therapy (SBR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0741202b78c3ae7acfd64d9ea4eb2fef
Autor:
Hervé Bercez, Luc Ceugnart, Sophie Taïeb, David Pasquier, F. Bachelle, Thomas Boulanger, Céline Chaveron, Nathalie Rocourt, Hajer Jarraya
Publikováno v:
Imagerie de la Femme. 25:76-87
Resume Une patiente traitee d’un cancer du sein doit beneficier d’un examen clinique semestriel et d’une mammographie annuelle en cas de traitement conservateur. En dehors des lesions infracliniques decouvertes lors du bilan d’imagerie, le ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd17bd235edf2405935788ea1d2d7e05
https://doi.org/10.1016/j.femme.2015.03.006
https://doi.org/10.1016/j.femme.2015.03.006
Autor:
Andrew Kramar, Luc Ceugnart, Thomas Boulanger, Thomas Lacornerie, Francois Bonodeau, Sophie Taïeb, Xavier Mirabel, Eric Lartigau, Emmanuelle Tresch, Hajer Jarraya, Chloé Chalayer
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 90:119-125
To report experience with fiducial marker insertion and describe an advantageous, novel technique for fiducial placement in the liver for stereotactic body radiation therapy with respiratory tracking.We implanted 1444 fiducials (single: 834; linked:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b075420cecfaaa183e8fc5509f6c8d3d
https://doi.org/10.1016/j.ijrobp.2014.05.002
https://doi.org/10.1016/j.ijrobp.2014.05.002
Publikováno v:
Imagerie de la Femme. 24:150-155
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9949717ee4439bbd85f77518574f1ac
https://doi.org/10.1016/j.femme.2014.07.005
https://doi.org/10.1016/j.femme.2014.07.005
Autor:
Thibault Mazard, Antonella Verrioli, Alessandro Pastorino, Daniela Redaelli, Joleen M. Hubbard, Katia Bencardino, Axel Grothey, Olivier Bouché, Hans Prenen, Yves Humblet, Konstantinos Papadimitriou, Antoine Adenis, Sophie Deguelte-Lardiere, Angelo Vanzulli, Luca Porcu, Alfredo Falcone, Marc Peeters, Andrea Sartore-Bianchi, Carlo Barone, Hajer Jarraya, Chiara Cremolini, Silvia Ghezzi, Giulia Carlo-Stella, Guillem Argiles, Josep Tabernero, Marc Ychou, Laurent Mineur, Riccardo Ricotta, Valter Torri, Marc Van den Eynde, Alessio Amatu, Alberto Sobrero, Salvatore Siena, Eric Van Cutsem, C. Funaioli
Publikováno v:
ESMO Open
European Society for Medical Oncology
European Society for Medical Oncology, BMJ Journals, 2017, 1 (6), pp.e000111. ⟨10.1136/esmoopen-2016-000111⟩
ESMO open, Vol. 1, p. e000111 (2016)
European Society for Medical Oncology, 2017, 1 (6), pp.e000111. ⟨10.1136/esmoopen-2016-000111⟩
European Society for Medical Oncology
European Society for Medical Oncology, BMJ Journals, 2017, 1 (6), pp.e000111. ⟨10.1136/esmoopen-2016-000111⟩
ESMO open, Vol. 1, p. e000111 (2016)
European Society for Medical Oncology, 2017, 1 (6), pp.e000111. ⟨10.1136/esmoopen-2016-000111⟩
OBJECTIVE: To identify imaging markers predicting clinical outcomes to regorafenib in metastatic colorectal carcinoma (mCRC). METHODS: The RadioCORRECT study is a post hoc analysis of a cohort of patients with mCRC treated within the phase III placeb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6985e9d56fe3fe09b285c878e288cfd4
https://hdl.handle.net/10067/1458030151162165141
https://hdl.handle.net/10067/1458030151162165141
Autor:
Hajer Jarraya, Sylvain Dewas, X. Mirabel, C. Dewas-Vautravers, Andrew Kramar, I. Fumagalli, E. Lartigau, T. Lacornerie
Publikováno v:
Cancer/Radiothérapie. 16:58-69
Resume Objectif de l’etude Le CyberKnife ® est un appareil de radiotherapie stereotaxique recent qui permet de traiter les lesions hepatiques tout en effectuant un tracking tumoral. Cette haute precision autorise une augmentation de la dose delivr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bda8c74da815fb6003ed6794615a4da1
https://doi.org/10.1016/j.canrad.2011.06.005
https://doi.org/10.1016/j.canrad.2011.06.005
Autor:
S. Cattan, E. Boleslawski, Didier Peiffert, Thomas Lacornerie, Jerome Durand-Labrunie, Hajer Jarraya, Xavier Mirabel
Publikováno v:
Radiotherapy and Oncology. 127:S57
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a97126e90b68105c705191f09456f9b2
https://doi.org/10.1016/s0167-8140(18)30415-8
https://doi.org/10.1016/s0167-8140(18)30415-8
Autor:
Fabrice Soncin, Farid El Hajbi, Anne Thirot-Bidault, Hajer Jarraya, François Ghiringhelli, Marie-Cécile Le Deley, Mohamed Bouchahda, Stephanie Clisant Delaine, Jean-Luc Raoul, Mohamed Hebbar, Fredrik Laestadius, Nicolas Penel, Sophie Taïeb, Antoine Adenis, Sylvaine Feutray, Emmanuelle Dochy, Eric Yaovi Amela, Julie Vincent, Nathalie Lassau, Emmanuelle Tresch
Publikováno v:
Journal of Clinical Oncology. 35:737-737
737 Background: A is approved in combination with FOLFIRI (A-FOLFIRI) for the treatment of mCRC patients (pts) previously treated with oxaliplatin. PULSAR trial (NCT02173990) aims to measure the activity A-FOLFIRI as 1st-line mCRC treatment. Key seco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2a0813884f63c709ddbf740c88d8b78
https://doi.org/10.1200/jco.2017.35.4_suppl.737
https://doi.org/10.1200/jco.2017.35.4_suppl.737